Skip to content
lifestyle.onlygolfnews.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Life Biosciences
Life Biosciences Announces First Patient Dosed in Phase 1 Trial of ER‑100 for Optic Neuropathies
June 9, 2026
Life Biosciences Secures $80 Million Series D Financing
April 8, 2026
Life Biosciences Announces FDA Clearance of IND Application for ER-100 in Optic Neuropathies
January 28, 2026